| . | Postoperative complication . | . | |
|---|---|---|---|
| . | No n = 297 . | Yes n = 109 . | P . |
| Age (years), mean(s.d.) | 55.2(7.2) | 56.7(6.1) | 0.38 |
| BMI (kg/m2), median (i.q.r.) | 27 (24–30) | 26 (24–30) | 0.975 |
| Sex | |||
| Women, n (%) | 160 (53.9) | 61 (56) | 0.793 |
| Men, n (%) | 137 (46.1) | 48 (44) | |
| Charlson index, median (i.q.r.)† | 1 (0–3) | 2 (1–3) | 0.025 |
| Alpha-blockers | |||
| Yes, n (%) | 274 (92.3) | 108 (99.1) | 0.36 |
| No, n (%) | 9 (3.0) | 0 (0.0) | |
| Beta-blockers | |||
| Yes, n (%) | 99 (33.0) | 47 (43.1) | 0.137 |
| No, n (%) | 183 (61.6) | 60 (55.0) | |
| Catecholamines | |||
| Lower quartile, n (%) | 217 (73.0) | 71 (65.1) | 0.055 |
| Upper quartile, n (%) | 62 (20.8) | 34 (31.1) | |
| Tumour size (cm), median (i.q.r.) | 4 (2.8–5.5) | 4.8 (3.2–7) | 0.006 |
| Tumour location | |||
| Right, n (%) | 147 (49.5) | 45 (41.3) | 0.251 |
| Left, n (%) | 137 (46.1) | 55 (50.5) | |
| Unknown, n (%) | 13 (4.3) | 9 (8.3) | |
| Approach‡ | |||
| Laparoscopic, n (%) | 264/321 (82.2) | 57/321 (17.8) | <0.001 |
| Converted to open, n (%) | 10/23 (43.4) | 13/23 (56.6) | |
| Open, n (%) | 21/58 (36.2) | 37/58 (63.8) | |
| . | Postoperative complication . | . | |
|---|---|---|---|
| . | No n = 297 . | Yes n = 109 . | P . |
| Age (years), mean(s.d.) | 55.2(7.2) | 56.7(6.1) | 0.38 |
| BMI (kg/m2), median (i.q.r.) | 27 (24–30) | 26 (24–30) | 0.975 |
| Sex | |||
| Women, n (%) | 160 (53.9) | 61 (56) | 0.793 |
| Men, n (%) | 137 (46.1) | 48 (44) | |
| Charlson index, median (i.q.r.)† | 1 (0–3) | 2 (1–3) | 0.025 |
| Alpha-blockers | |||
| Yes, n (%) | 274 (92.3) | 108 (99.1) | 0.36 |
| No, n (%) | 9 (3.0) | 0 (0.0) | |
| Beta-blockers | |||
| Yes, n (%) | 99 (33.0) | 47 (43.1) | 0.137 |
| No, n (%) | 183 (61.6) | 60 (55.0) | |
| Catecholamines | |||
| Lower quartile, n (%) | 217 (73.0) | 71 (65.1) | 0.055 |
| Upper quartile, n (%) | 62 (20.8) | 34 (31.1) | |
| Tumour size (cm), median (i.q.r.) | 4 (2.8–5.5) | 4.8 (3.2–7) | 0.006 |
| Tumour location | |||
| Right, n (%) | 147 (49.5) | 45 (41.3) | 0.251 |
| Left, n (%) | 137 (46.1) | 55 (50.5) | |
| Unknown, n (%) | 13 (4.3) | 9 (8.3) | |
| Approach‡ | |||
| Laparoscopic, n (%) | 264/321 (82.2) | 57/321 (17.8) | <0.001 |
| Converted to open, n (%) | 10/23 (43.4) | 13/23 (56.6) | |
| Open, n (%) | 21/58 (36.2) | 37/58 (63.8) | |
*Data available for 406 patients. †Age-adjusted Charlson Co-morbidity Index. ‡Data for surgical approach are presented horizontally, calculating the percentages on the total number of procedures available. Bold values represent statistical significance.
| . | Postoperative complication . | . | |
|---|---|---|---|
| . | No n = 297 . | Yes n = 109 . | P . |
| Age (years), mean(s.d.) | 55.2(7.2) | 56.7(6.1) | 0.38 |
| BMI (kg/m2), median (i.q.r.) | 27 (24–30) | 26 (24–30) | 0.975 |
| Sex | |||
| Women, n (%) | 160 (53.9) | 61 (56) | 0.793 |
| Men, n (%) | 137 (46.1) | 48 (44) | |
| Charlson index, median (i.q.r.)† | 1 (0–3) | 2 (1–3) | 0.025 |
| Alpha-blockers | |||
| Yes, n (%) | 274 (92.3) | 108 (99.1) | 0.36 |
| No, n (%) | 9 (3.0) | 0 (0.0) | |
| Beta-blockers | |||
| Yes, n (%) | 99 (33.0) | 47 (43.1) | 0.137 |
| No, n (%) | 183 (61.6) | 60 (55.0) | |
| Catecholamines | |||
| Lower quartile, n (%) | 217 (73.0) | 71 (65.1) | 0.055 |
| Upper quartile, n (%) | 62 (20.8) | 34 (31.1) | |
| Tumour size (cm), median (i.q.r.) | 4 (2.8–5.5) | 4.8 (3.2–7) | 0.006 |
| Tumour location | |||
| Right, n (%) | 147 (49.5) | 45 (41.3) | 0.251 |
| Left, n (%) | 137 (46.1) | 55 (50.5) | |
| Unknown, n (%) | 13 (4.3) | 9 (8.3) | |
| Approach‡ | |||
| Laparoscopic, n (%) | 264/321 (82.2) | 57/321 (17.8) | <0.001 |
| Converted to open, n (%) | 10/23 (43.4) | 13/23 (56.6) | |
| Open, n (%) | 21/58 (36.2) | 37/58 (63.8) | |
| . | Postoperative complication . | . | |
|---|---|---|---|
| . | No n = 297 . | Yes n = 109 . | P . |
| Age (years), mean(s.d.) | 55.2(7.2) | 56.7(6.1) | 0.38 |
| BMI (kg/m2), median (i.q.r.) | 27 (24–30) | 26 (24–30) | 0.975 |
| Sex | |||
| Women, n (%) | 160 (53.9) | 61 (56) | 0.793 |
| Men, n (%) | 137 (46.1) | 48 (44) | |
| Charlson index, median (i.q.r.)† | 1 (0–3) | 2 (1–3) | 0.025 |
| Alpha-blockers | |||
| Yes, n (%) | 274 (92.3) | 108 (99.1) | 0.36 |
| No, n (%) | 9 (3.0) | 0 (0.0) | |
| Beta-blockers | |||
| Yes, n (%) | 99 (33.0) | 47 (43.1) | 0.137 |
| No, n (%) | 183 (61.6) | 60 (55.0) | |
| Catecholamines | |||
| Lower quartile, n (%) | 217 (73.0) | 71 (65.1) | 0.055 |
| Upper quartile, n (%) | 62 (20.8) | 34 (31.1) | |
| Tumour size (cm), median (i.q.r.) | 4 (2.8–5.5) | 4.8 (3.2–7) | 0.006 |
| Tumour location | |||
| Right, n (%) | 147 (49.5) | 45 (41.3) | 0.251 |
| Left, n (%) | 137 (46.1) | 55 (50.5) | |
| Unknown, n (%) | 13 (4.3) | 9 (8.3) | |
| Approach‡ | |||
| Laparoscopic, n (%) | 264/321 (82.2) | 57/321 (17.8) | <0.001 |
| Converted to open, n (%) | 10/23 (43.4) | 13/23 (56.6) | |
| Open, n (%) | 21/58 (36.2) | 37/58 (63.8) | |
*Data available for 406 patients. †Age-adjusted Charlson Co-morbidity Index. ‡Data for surgical approach are presented horizontally, calculating the percentages on the total number of procedures available. Bold values represent statistical significance.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
